Pancreatic Adenocarcinoma
Conditions
Brief summary
This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.
Detailed description
PRIMARY OBJECTIVE: I. To assess the feasibility of utilizing a mobile application for patients to self-track the time burden associated with undergoing pancreatic cancer treatment. OUTLINE: Patients download the MyCap app onto their phone and fill out a daily time log in the app for 8 weeks.
Interventions
OTHERElectronic Health Record Review
Ancillary studies
Receive access to MyCap application
OTHERSurvey Administration
Ancillary studies
Sponsors
Ohio State University Comprehensive Cancer Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults ≥ 18 years old * Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days * English speaking * Access to a smartphone (Android or iOS)
Exclusion criteria
* Prisoners * Patients undergoing cancer surveillance
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Retention rate (feasibility) | Up to 8 weeks | Defined as the number of participants who enroll in the study and complete at least one time log during the study period. |
| Adherence rate (feasibility) | Up to 8 weeks | Adherence is defined as the percentage of patients who completed over 80% of time logs. Given that this study is evaluating a daily time log over 8 weeks, adherence would require participants to fill out at least 44-time logs. |
| System usability survey (feasibility) | Up to 8 weeks | — |
Countries
United States
Contacts
CONTACTThe Ohio State University Comprehensive Cancer Center
PRINCIPAL_INVESTIGATORPamela W Lu, MD
Ohio State University Comprehensive Cancer Center
Outcome results
None listed